From 11:00 pm to 12:00 pm EST ( 8:00 pm to 9:00 pm PST ) on January 6th, the website will be under maintenance. We are sorry for the inconvenience. Please arrange your schedule properly.
Galectin-3-IN-4 (compound 5) is a carboxamide analog. Galectin-3-IN-4 is a potent, selective, and orally bioavailable inhibitor of human and mouse galectin-3, with IC50 values of 21 and 167 nM for hGal-3 and mGal-3, respectively. Galectin-3-IN-4 has IC50 values of 1580 and 2750 nM for hGal-1 and hGal-9, respectively .
Galectin-3/galectin-8-IN-1 (Compound 53) is a dual Galectin-3 and galectin-8 C-terminal domain inhibitor, with Kd values of 4.12 μM and 6.04 μM respectively. Galectin-3/galectin-8-IN-1 inhibits the MRC-5 lung fibroblast cells migration. Galectin-3/galectin-8-IN-1 can be used for research of cancer and tissue fibrosis .
Galectin-3/galectin-8-IN-2 (Compound 57) is a dual Galectin-3 and galectin-8 C-terminal domain inhibitor, with Kd values of 12.8 μM and 2.06 μM respectively. Galectin-3/galectin-8-IN-2 inhibits the MRC-5 lung fibroblast cells migration. Galectin-3/galectin-8-IN-2 can be used for research of cancer and tissue fibrosis .
Galectin-8-IN-1 is a selective ligand for the galectin-8 N-terminal domain (galectin-8N), with a Kd of 48 μM and 15-fold selectivity over galectin-3 and even better selectivity over the other mammalian galectins.
Galectin-8N-IN-1 (compound 19a) is a potent and selective galectin-8N inhibitor with a Kd value of 1.8 μM. Galectin-8N-IN-1 is a galectin-8N ligand. Galectin-8N-IN-1 can be used in research of immune system .
Galectin-3-IN-2 (Compound 9) is a potent multivalent inhibitor of galectin-3 (Gal-3; IC50=8.3 μM). Galectin-3 participates in many cancer-related metabolic processes .
Galectin-3-IN-1 (Compound 1) is a potent multivalent inhibitor of galectin-3 (Gal-3). Galectin-3 participates in many cancer-related metabolic processes . Galectin-3-IN-1 is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
Galectin-3 antagonist 1 (compound 15) is a potent and selective Galectin-3 (Gal-3) antagonist with Kd value of 5.3 μM. Meanwhile, Galectin-3 antagonist 1 binds to various Galectin with Kd values of 250 μM (Gal-4N), 18 μM (Gal-4C), 450 μM (Gal-8C), respectively .
Galectin-3-IN-3 (Compound 4) is an orally active and selective inhibitor of Gal-3, with IC50 values of 11 nM and 84 nM against mGal-3 and hGal-3 respectively .
Galectin-3 is a β Galactoside specific carbohydrate recognition protein (lectin) has the ability to promote the migration of B cell precursor acute lymphoblastic leukemia (BCP-ALL) cells and withstand drug research.
GB1107 is a potent, selective, orally active inhibitor of Galectin-3 (Gal-3) with a Kd of 37 nM for human Galectin-3. GB1107 reduces human and mouse lung adenocarcinoma growth and blocks metastasis in the syngeneic model .
Apoptosis inducer 8 (Compound 7c) is a galectin-1 (gal-1) mediated apoptosis-inducing agent against global major leading lung cancer burden. Apoptosis inducer 8 significantly reduced the gal-1 protein level. Apoptosis inducer 8 is also a PET imaging agent .
Belapectin (GR-MD-02) is a Galectin-3 (Gal-3) inhibitor. Belapectin drives tumor-induced immunosuppression by inducing T cell Apoptosis. Belapectin promotes tumor regression and improves survival of tumor-bearing mice through a CD8+ T cell-dependent mechanism. Belapectin binds to Gal-3 with affinity Ki of 2.8 μM .
Propargyl-PEG5-acid is a non-cleavable 5 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs). Propargyl-PEG5-acid can used to synthesize ADC inhibitors of Galectin-3. Propargyl-PEG5-acid is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs . Propargyl-PEG5-acid is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
Propargyl-PEG4-CH2CH2-Boc is a non-cleavable ADC linker that can be used to synthesize ADC inhibitors of Galectin-3. Propargyl-PEG4-CH2CH2-Boc is a PEG- and Alkyl/ether-based PROTAC linker that can be used in the synthesis of PROTACs . Propargyl-PEG4-CH2CH2-Boc is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
Thiodigalactoside (TDG) is an orally active and potent galectin (GAL) inhibitor with Kd values of 24 μM, 49 μM for GAL1 and GAL3, respectively . Thiodigalactoside, a non-metabolizable disaccharide, has anti-inflammatory and anti-cancer activity. Thiodigalactoside dramatically reduces body weight gain in diet-induced obese rats .
The Galectin-2 (LGALS2) protein binds with affinity to β-galactopyranoside and forms homodimers, indicating a basic functional organization. Although the physiological role is unclear, β-galactoside binding of LGALS2 suggests a possible involvement in recognition of specific carbohydrates. Animal-Free Galectin-2/LGALS2 Protein, Human (His) is the recombinant human-derived animal-FreeGalectin-2/LGALS2 protein, expressed by E. coli , with N-His labeled tag. The total length of Animal-Free Galectin-2/LGALS2 Protein, Human (His) is 131 a.a., with molecular weight of ~15.5 kDa.
Galectin-9/LGALS9 Protein, an eosinophil chemoattractant, directs the migration of eosinophils, key immune cells in inflammatory responses. It also functions as an angiogenesis inhibitor, regulating blood vessel formation. Beyond cellular trafficking and vascular processes, Galectin-9/LGALS9 modulates immune responses by suppressing interferon-gamma (IFNG) production in natural killer cells, exerting regulatory control over immune signaling pathways. Galectin-9/LGALS9 Protein, Mouse (GST) is the recombinant mouse-derived Galectin-9/LGALS9 protein, expressed by E. coli, with N-GST labeled tag. The total length of Galectin-9/LGALS9 Protein, Mouse (GST) is 322 a.a., with molecular weight of ~60.0 kDa.
The Galectin-2 (LGALS2) protein binds with affinity to β-galactopyranoside and forms homodimers, indicating a basic functional organization. Although the physiological role is unclear, β-galactoside binding of LGALS2 suggests a possible involvement in recognition of specific carbohydrates. Galectin-2/LGALS2 Protein, Human (GST) is the recombinant human-derived Galectin-2/LGALS2 protein, expressed by E. coli , with N-GST labeled tag. The total length of Galectin-2/LGALS2 Protein, Human (GST) is 132 a.a., with molecular weight of ~41.6 kDa.
Galectin-1/LGALS1 is a lectin that binds β-galactoside and complex carbohydrates and regulates apoptosis, proliferation, and differentiation. It inhibits CD45 phosphatase activity, blocks Lyn kinase dephosphorylation, and induces T cell apoptosis. Galectin-1/LGALS1 Protein, Human is the recombinant human-derived Galectin-1/LGALS1 protein, expressed by E. coli , with tag free. The total length of Galectin-1/LGALS1 Protein, Human is 135 a.a., with molecular weight of ~15 kDa.
Galectin-1/LGALS1 protein is a β-galactoside-binding lectin that regulates apoptosis, cell proliferation and differentiation by inhibiting CD45 protein phosphatase activity and preventing Lyn kinase dephosphorylation. As a homodimer, it induces T cell apoptosis and interacts with CD2, CD3, CD4, CD6, CD7, CD43, ALCAM, CD45, laminin, and SUSD2. Galectin-1/LGALS1 Protein, Rat is the recombinant rat-derived Galectin-1/LGALS1 protein, expressed by E. coli , with tag free. The total length of Galectin-1/LGALS1 Protein, Rat is 134 a.a., with molecular weight of ~13 kDa.
Galectin-8/LGALS8 Protein, a vital enzyme in glycosylation, serves as a beta-1,3-N-acetylglucosaminyltransferase, synthesizing poly-N-acetyllactosamine. Crucial for modifying glycoproteins and glycolipids, Galectin-8/LGALS8 catalyzes N-acetylglucosamine transfer onto acceptor molecules, exhibiting specific activity for type 2 oligosaccharides. Its role in poly-N-acetyllactosamine synthesis emphasizes its significance in modulating cellular interactions, impacting various processes like cell adhesion, signaling, and recognition events through glycan structure alterations. Galectin-8/LGALS8 Protein, Human (GST) is the recombinant human-derived Galectin-8/LGALS8 protein, expressed by E. coli, with N-GST labeled tag. The total length of Galectin-8/LGALS8 Protein, Human (GST) is 317 a.a., with molecular weight of 62.8 kDa.
Galectin-4/LGALS4 is a lactose-binding galectin protein with affinity for a variety of sugars. It is associated with the formation of adherens junctions, suggesting its potential role in cell adhesion processes. Galectin-4/LGALS4 Protein, Human (His) is the recombinant human-derived Galectin-4/LGALS4 protein, expressed by E. coli , with C-6*His labeled tag. The total length of Galectin-4/LGALS4 Protein, Human (His) is 323 a.a., with molecular weight of 35-38 kDa.
Galectin-12 protein exhibits lactose binding, indicating affinity for specific carbohydrate moieties. Some people believe that Galectin-12 may contribute to adipocyte apoptosis, suggesting that it plays a role in the regulation of adipose tissue homeostasis and programmed cell death. Animal-Free Galectin-12 Protein, Human (His) is the recombinant human-derived animal-FreeGalectin-12 protein, expressed by E. coli , with N-His labeled tag. The total length of Animal-Free Galectin-12 Protein, Human (His) is 335 a.a., with molecular weight of ~38.4 kDa.
Galectin-9/LGALS9 Protein acts as an eosinophil chemoattractant, recruiting and migrating eosinophils, key immune cells in inflammatory responses. It also serves as an angiogenesis inhibitor, regulating blood vessel formation and impacting vascular processes. Functioning as a regulatory modulator, Galectin-9/LGALS9 suppresses interferon-gamma (IFNG) production by natural killer cells, exerting control over immune signaling pathways. Galectin-9/LGALS9 Protein, Human (HEK293, His) is the recombinant human-derived Galectin-9/LGALS9 protein, expressed by HEK293, with C-6*His labeled tag. The total length of Galectin-9/LGALS9 Protein, Human (HEK293, His) is 323 a.a., with molecular weight of ~50.0 kDa.
Galectin-1/LGALS1 protein is a β-galactoside-binding lectin that regulates apoptosis, cell proliferation, and differentiation by inhibiting CD45 protein phosphatase. It prevents Lyn kinase dephosphorylation, induces T cell apoptosis as a homodimer, and interacts with CD2, CD3, CD4, CD6, CD7, CD43, ALCAM and CD45. Galectin-1/LGALS1 Protein, Mouse is the recombinant mouse-derived Galectin-1/LGALS1 protein, expressed by E. coli , with tag free. The total length of Galectin-1/LGALS1 Protein, Mouse is 135 a.a., with molecular weight of ~15 kDa.
Galectin-9/LGALS9 Protein acts as an eosinophil chemoattractant, recruiting and migrating eosinophils, key immune cells in inflammatory responses. It also serves as an angiogenesis inhibitor, regulating blood vessel formation and impacting vascular processes. Functioning as a regulatory modulator, Galectin-9/LGALS9 suppresses interferon-gamma (IFNG) production by natural killer cells, exerting control over immune signaling pathways. Galectin-9/LGALS9 Protein, Human (HEK293, hFc) is the recombinant human-derived Galectin-9/LGALS9 protein, expressed by HEK293, with N-hFc labeled tag. The total length of Galectin-9/LGALS9 Protein, Human (HEK293, hFc) is 322 a.a., with molecular weight of ~64.8 kDa.
Galectin-8/LGALS8 Protein, a vital enzyme in glycosylation, serves as a beta-1,3-N-acetylglucosaminyltransferase, synthesizing poly-N-acetyllactosamine. Crucial for modifying glycoproteins and glycolipids, Galectin-8/LGALS8 catalyzes N-acetylglucosamine transfer onto acceptor molecules, exhibiting specific activity for type 2 oligosaccharides. Its role in poly-N-acetyllactosamine synthesis emphasizes its significance in modulating cellular interactions, impacting various processes like cell adhesion, signaling, and recognition events through glycan structure alterations. Animal-Free Galectin-8/LGALS8 Protein, Human (His) is the recombinant human-derived animal-FreeGalectin-8/LGALS8 protein, expressed by E. coli, with N-His labeled tag. The total length of Animal-Free Galectin-8/LGALS8 Protein, Human (His) is 316 a.a., with molecular weight of ~36.6 kDa.
Galectin-7 (LGALS7), a protein with potential involvement in cell-cell and/or cell-matrix interactions crucial for normal growth control, serves as a pro-apoptotic factor. It functions intracellularly, playing a role upstream of JNK activation and cytochrome c release, thus contributing to apoptotic pathways. Galectin-7 exists as a monomer, highlighting its individual unit structure. Animal-Free Galectin-7/LGALS7 Protein, Human (His) is the recombinant human-derived animal-FreeGalectin-7/LGALS7 protein, expressed by E. coli , with N-His labeled tag. The total length of Animal-Free Galectin-7/LGALS7 Protein, Human (His) is 135 a.a., with molecular weight of ~15.9 kDa.
Galectin-4/LGALS4 is a lactose-binding galectin protein with affinity for a variety of sugars. It is associated with the formation of adherens junctions, suggesting its potential role in cell adhesion processes. Animal-Free Galectin-4/LGALS4 Protein, Human (His) is the recombinant human-derived animal-FreeGalectin-4/LGALS4 protein, expressed by E. coli , with N-His, N-His labeled tag. The total length of Animal-Free Galectin-4/LGALS4 Protein, Human (His) is 322 a.a., with molecular weight of ~36.8 kDa.
Galectin-9/LGALS9 Protein acts as an eosinophil chemoattractant, recruiting and migrating eosinophils, key immune cells in inflammatory responses. It also serves as an angiogenesis inhibitor, regulating blood vessel formation and impacting vascular processes. Functioning as a regulatory modulator, Galectin-9/LGALS9 suppresses interferon-gamma (IFNG) production by natural killer cells, exerting control over immune signaling pathways. Galectin-9/LGALS9 Protein, Human (GST) is the recombinant human-derived Galectin-9/LGALS9 protein, expressed by E. coli , with N-GST labeled tag. The total length of Galectin-9/LGALS9 Protein, Human (GST) is 323 a.a., with molecular weight of ~60.0 kDa.
Galectin-7 (LGALS7), a protein with potential involvement in cell-cell and/or cell-matrix interactions crucial for normal growth control, serves as a pro-apoptotic factor. It functions intracellularly, playing a role upstream of JNK activation and cytochrome c release, thus contributing to apoptotic pathways. Galectin-7 exists as a monomer, highlighting its individual unit structure. Galectin-7/LGALS7 Protein, Human (GST) is the recombinant human-derived Galectin-7/LGALS7 protein, expressed by E. coli , with N-GST labeled tag. The total length of Galectin-7/LGALS7 Protein, Human (GST) is 135 a.a., with molecular weight of ~41.8 kDa.
Galectin-1/LGALS1 protein is a β-galactoside-binding lectin that regulates apoptosis, cell proliferation, and differentiation by inhibiting CD45 protein phosphatase. It prevents Lyn kinase dephosphorylation, induces T cell apoptosis as a homodimer, and interacts with CD2, CD3, CD4, CD6, CD7, CD43, ALCAM and CD45. Galectin-1/LGALS1 Protein, Mouse (HEK293, Fc) is the recombinant mouse-derived Galectin-1/LGALS1 protein, expressed by HEK293 , with N-hFc labeled tag. The total length of Galectin-1/LGALS1 Protein, Mouse (HEK293, Fc) is 134 a.a., with molecular weight of 45-52 kDa.
Galectin-8/LGALS8 Protein, a vital enzyme in glycosylation, serves as a beta-1,3-N-acetylglucosaminyltransferase, synthesizing poly-N-acetyllactosamine. Crucial for modifying glycoproteins and glycolipids, Galectin-8/LGALS8 catalyzes N-acetylglucosamine transfer onto acceptor molecules, exhibiting specific activity for type 2 oligosaccharides. Its role in poly-N-acetyllactosamine synthesis emphasizes its significance in modulating cellular interactions, impacting various processes like cell adhesion, signaling, and recognition events through glycan structure alterations. Galectin-8/LGALS8 Protein, Human is the recombinant human-derived Galectin-8/LGALS8 protein, expressed by E. coli, with tag free. The total length of Galectin-8/LGALS8 Protein, Human is 317 a.a., with molecular weight of ~36 kDa.
Galectin-7 (LGALS7), a protein with potential involvement in cell-cell and/or cell-matrix interactions crucial for normal growth control, serves as a pro-apoptotic factor. It functions intracellularly, playing a role upstream of JNK activation and cytochrome c release, thus contributing to apoptotic pathways. Galectin-7 exists as a monomer, highlighting its individual unit structure. Galectin-7/LGALS7 Protein, Human is the recombinant human-derived Galectin-7/LGALS7 protein, expressed by E. coli , with tag free. The total length of Galectin-7/LGALS7 Protein, Human is 136 a.a., with molecular weight of ~14.0 kDa.
The LGALSL protein was identified as a member of the galectin family, exhibits no affinity for lactose, and may not be involved in carbohydrate binding. This unique feature distinguishes LGALSL from typical galectins, which are known for their carbohydrate recognition domain and interaction with specific sugar moieties. LGALSL Protein, Human (His) is the recombinant human-derived LGALSL protein, expressed by E. coli , with C-6*His labeled tag. The total length of LGALSL Protein, Human (His) is 171 a.a., with molecular weight of ~18.0 kDa.
PPL13/LGALS14 is a mammalian placenta-specific galectin with placental specificity. Many placental lectins induce apoptosis of activated T cells and other leukocytes, thereby conferring immune tolerance to the recipient. Galectin-14/LGALS14 Protein, Human (HEK293, His) is the recombinant human-derived Galectin-14/LGALS14 protein, expressed by HEK293 , with C-6*His labeled tag. The total length of Galectin-14/LGALS14 Protein, Human (HEK293, His) is 139 a.a., with molecular weight of ~16.0 kDa.
Galectin-14/LGALS14 Protein, with beta-galactoside and lactose binding capabilities, acts as a potent inducer of T-cell apoptosis, highlighting its crucial role in immune response regulation. Its specific binding to beta-galactoside and lactose implies involvement in cellular processes governed by these molecules, emphasizing the diverse functions of Galectin-14/LGALS14 in modulating immune activity and potentially contributing to broader physiological processes. Animal-Free Galectin-14/LGALS14 Protein, Human (His) is the recombinant human-derived animal-FreeGalectin-14/LGALS14 protein, expressed by E. coli, with N-His labeled tag. The total length of Animal-Free Galectin-14/LGALS14 Protein, Human (His) is 138 a.a., with molecular weight of ~16.9 kDa.
Galectin-3/LGALS3 protein binds IgE and cooperates with integrins α-3 and β-1 to promote endothelial cell migration. It contributes to epithelial cell differentiation and acts as a splicing factor in the nucleus. Galectin-3/LGALS3 Protein, Mouse (HEK293, His) is the recombinant mouse-derived Galectin-3/LGALS3 protein, expressed by HEK293 , with C-His labeled tag. The total length of Galectin-3/LGALS3 Protein, Mouse (HEK293, His) is 263 a.a., with molecular weight of 40-50 kDa.
The Galectin-3/LGALS3 protein is a galactose-specific lectin known for its diverse roles in cellular processes. It binds IgE and synergizes with α-3 and β-1 integrins to promote CSPG4-induced endothelial cell migration. Galectin-3/LGALS3 Protein, Cynomolgus (HEK293, His) is the recombinant cynomolgus-derived Galectin-3/LGALS3 protein, expressed by HEK293 , with N-His labeled tag. The total length of Galectin-3/LGALS3 Protein, Cynomolgus (HEK293, His) is 247 a.a., with molecular weight of 35-48 kDa.
The Galectin-3/LGALS3 protein is a galactose-specific lectin known for its diverse roles in cellular processes. It binds IgE and synergizes with α-3 and β-1 integrins to promote CSPG4-induced endothelial cell migration. Galectin-3/LGALS3 Protein, Human is the recombinant human-derived Galectin-3/LGALS3 protein, expressed by E. coli , with tag free. The total length of Galectin-3/LGALS3 Protein, Human is 249 a.a., with molecular weight of ~30.0 kDa.
The Galectin-3/LGALS3 protein is a galactose-specific lectin known for its diverse roles in cellular processes. It binds IgE and synergizes with α-3 and β-1 integrins to promote CSPG4-induced endothelial cell migration. Animal-Free Galectin-3/LGALS3 Protein, Human (His) is the recombinant human-derived animal-FreeGalectin-3/LGALS3 protein, expressed by E. coli , with N-His labeled tag. The total length of Animal-Free Galectin-3/LGALS3 Protein, Human (His) is 249 a.a., with molecular weight of ~27 kDa.
The Galectin-3/LGALS3 protein is a galactose-specific lectin known for its diverse roles in cellular processes. It binds IgE and synergizes with α-3 and β-1 integrins to promote CSPG4-induced endothelial cell migration. Galectin-3/LGALS3 Protein, Human (HEK293, His) is the recombinant human-derived Galectin-3/LGALS3 protein, expressed by HEK293 , with C-6*His labeled tag. The total length of Galectin-3/LGALS3 Protein, Human (HEK293, His) is 249 a.a., with molecular weight of 33-36 kDa.
Galectin-1/LGALS1 is a lectin that binds β-galactoside and complex carbohydrates and regulates apoptosis, proliferation, and differentiation. It inhibits CD45 phosphatase activity, blocks Lyn kinase dephosphorylation, and induces T cell apoptosis. Galectin-1/LGALS1 Protein, Human (His) is the recombinant human-derived Galectin-1/LGALS1 protein, expressed by E. coli , with C-6*His labeled tag. The total length of Galectin-1/LGALS1 Protein, Human (His) is 134 a.a., with molecular weight of ~15.0 kDa.
Galectin-16 is a soluble β-galactoside binding protein that regulates key biological processes such as cell growth, differentiation, apoptosis and immune response. Galectin-16 alters expression associated with cancer, diabetes, and brain disease. Animal-Free Galectin-16 Protein, Human (His) is the recombinant human-derived animal-FreeGalectin-16 protein, expressed by E. coli , with N-His labeled tag. The total length of Animal-Free Galectin-16 Protein, Human (His) is 141 a.a., with molecular weight of ~17.4 kDa.
Galectin-13 Protein, with beta-galactoside and lactose binding capacity, acts as a potent inducer of T-cell apoptosis, as confirmed by research findings. It also exhibits hemagglutinating activity towards chicken erythrocytes, as reported in studies. Structurally, Galectin-13 Protein exists as a homodimer, maintained by disulfide linkages contributing to its dimeric form. Animal-Free Galectin-13 Protein, Human (His) is the recombinant human-derived animal-FreeGalectin-13 protein, expressed by E. coli, with N-His labeled tag. The total length of Animal-Free Galectin-13 Protein, Human (His) is 138 a.a., with molecular weight of ~16.9 kDa.
Galectin-9/LGALS9 Protein acts as an eosinophil chemoattractant, recruiting and migrating eosinophils, key immune cells in inflammatory responses. It also serves as an angiogenesis inhibitor, regulating blood vessel formation and impacting vascular processes. Functioning as a regulatory modulator, Galectin-9/LGALS9 suppresses interferon-gamma (IFNG) production by natural killer cells, exerting control over immune signaling pathways. Animal-Free Galectin-9/LGALS9 Protein, Human (His) is the recombinant human-derived animal-FreeGalectin-9/LGALS9 protein, expressed by E. coli, with N-His labeled tag. The total length of Animal-Free Galectin-9/LGALS9 Protein, Human (His) is 322 a.a., with molecular weight of ~36.7 kDa.
Galectin-10 Protein, pivotal in immune regulation, recognizes cell-surface glycans, inducing anergy and suppressing CD25-positive regulatory T-cells (Treg). Interacting with CEL, it modulates immune responses, highlighting its significance in orchestrating immunoregulatory cellular processes. Animal-Free Galectin-10 Protein, Human (His) is the recombinant human-derived animal-FreeGalectin-10 protein, expressed by E. coli, with N-His labeled tag. The total length of Animal-Free Galectin-10 Protein, Human (His) is 141 a.a., with molecular weight of ~36.7 kDa.
Galectin-1/LGALS1 is a lectin that binds β-galactoside and complex carbohydrates and regulates apoptosis, proliferation, and differentiation. It inhibits CD45 phosphatase activity, blocks Lyn kinase dephosphorylation, and induces T cell apoptosis. Animal-Free Galectin-1/LGALS1 Protein, Human (His) is the recombinant human-derived animal-FreeGalectin-1/LGALS1 protein, expressed by E. coli , with N-His labeled tag. The total length of Animal-Free Galectin-1/LGALS1 Protein, Human (His) is 134 a.a., with molecular weight of ~15.5 kDa.
Galectin 1 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 15 kDa, targeting to Galectin 1. It can be used for WB,ICC/IF,IHC-P,IP,FC assays with tag free, in the background of Human, Mouse, Rat.
Galectin 3 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 26 kDa, targeting to Galectin 3. It can be used for WB,ICC/IF,FC,IHC-P assays with tag free, in the background of Human, Mouse.
Galectin-3-IN-1 (Compound 1) is a potent multivalent inhibitor of galectin-3 (Gal-3). Galectin-3 participates in many cancer-related metabolic processes . Galectin-3-IN-1 is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
Propargyl-PEG5-acid is a non-cleavable 5 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs). Propargyl-PEG5-acid can used to synthesize ADC inhibitors of Galectin-3. Propargyl-PEG5-acid is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs . Propargyl-PEG5-acid is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
Propargyl-PEG4-CH2CH2-Boc is a non-cleavable ADC linker that can be used to synthesize ADC inhibitors of Galectin-3. Propargyl-PEG4-CH2CH2-Boc is a PEG- and Alkyl/ether-based PROTAC linker that can be used in the synthesis of PROTACs . Propargyl-PEG4-CH2CH2-Boc is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
Galectin-3-IN-2 (Compound 9) is a potent multivalent inhibitor of galectin-3 (Gal-3; IC50=8.3 μM). Galectin-3 participates in many cancer-related metabolic processes .
Inquiry Online
Your information is safe with us. * Required Fields.
![6Lac[6]Met](http://file.medchemexpress.com/product_pic/hy-157824.gif)
